Creative Destruction Lab – Graduates of 2023/2024

We are excited to highlight the graduates of the CDL-Global #AdvancedTherapies and #Cancer streams this year. A big round of applause to the dedication of the ventures throughout the program. These companies are at the forefront of innovation in #healthtech and are set to make a significant impact in the industry. CDL-Global Streams are supported […]

Join us at BIO International Convention #BIO2024

โŒ›Time is running out for the #BIO2024 International Convention, next week. Only a few slots are left to meet Paul Bravetti (CEO) and Lรฉa Perles (Strategic Operations Lead) โžก๏ธ๐—Ÿ๐—ผ๐—ด ๐—ถ๐—ป๐˜๐—ผ ๐—•๐Ÿฎ๐—• ๐—ฝ๐—ฎ๐—ฟ๐˜๐—ป๐—ฒ๐—ฟ๐—ถ๐—ป๐—ด ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ for a 30′ meeting : https://lnkd.in/dBejSc4j A unique opportunity to discuss our latest advancements and explore new collaboration opportunities. ๐Ÿ“…Dates: [June 3-6] […]

Join us at ASCO 2024

Next week at #ASCO24 ๐Ÿ’กโ€œ๐—•๐—ฟ๐—ฒ๐—”๐—ž ๐—–๐—ฅ๐—–, ๐—ฎ ๐—ณ๐—ถ๐—ฟ๐˜€๐˜-๐—ถ๐—ป-๐—ต๐˜‚๐—บ๐—ฎ๐—ป ๐—ฝ๐—ต๐—ฎ๐˜€๐—ฒ ๐—œ/๐—œ๐—œ ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ผ๐—ณ ๐—ฆ๐—ง๐—–-๐Ÿญ๐Ÿฌ๐Ÿญ๐Ÿฌ, ๐—ฎ ๐—ป๐—ฒ๐˜„ ๐—ฎ๐—น๐—น๐—ผ๐—ด๐—ฒ๐—ป๐—ถ๐—ฐ ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐˜ƒ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฎ๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฑ ๐—ผ๐—ฟ ๐—บ๐—ฒ๐˜๐—ฎ๐˜€๐˜๐—ฎ๐˜๐—ถ๐—ฐ ๐˜‚๐—ป๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฐ๐˜๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฐ๐—ผ๐—น๐—ผ๐—ฟ๐—ฒ๐—ฐ๐˜๐—ฎ๐—น ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ.โ€ Brenus Pharma is excited to present a new poster accepted at American Society of Clinical Oncology (ASCO) annual meeting in Chicago during the โ€œTrials in Progressโ€ session. โฌ‡๏ธ Contact & […]

Brenus Pharma, French ambassador #Boosters

Brenus Pharma, French ambassador #Boosters ! Last night we received the hashtag#Healthcare ๐Ÿ’™๐Ÿคโค๏ธ award from Business France, who are constantly and effectively committed to strengthening our international attractiveness and promoting our mission to meet the needs of patients, in France and beyond borders. We are honored to be recognized among a core group of innovative […]

Join us at MEET2WIN 2024

Join us tomorrow at the #Meet2Win – European Oncology Partnering Convention in Bordeaux ๐Ÿ“ organized by MATWIN ! Thank you for bringing us the opportunity to present Brenus Pharma‘s latest developments and upcoming collaboartions during the “๐™ˆ๐™€๐™€๐™ ๐™ˆ๐™ฎ ๐˜ผ๐™ก๐™ข๐™ช๐™ฃ๐™ž ๐™‹๐™Š๐™Ž๐™๐™€๐™ ๐™Ž๐™€๐™Ž๐™Ž๐™„๐™Š๐™‰” [16th โฒ๏ธ 6 to 7 pm – HALL & 17th โฒ๏ธ10 to 11 am […]

Join us at BIO Europe Spring

๐Ÿ“ข Last chance to schedule a meeting and connect with our CEO Paul Bravetti, at BIO- Europe Spring convention next week. hashtag#BES24 ๐Ÿ“ข โžก๏ธ A good opportunity to find out the recent achivements we made and the upcoming clinical development plan. Click here : https://lnkd.in/eudjdypq BIO-Europe Spring, the premier springtime partnering event takes place in […]

Hybridays 2024

Corinne Tortorelli & Lรฉa Perles had the honor last week of participating as a talented #Biotech in the 2nd edition of the #Hybridays dedicated this year to “the next generations of gene and cell therapies”. High-quality expert reviews, strategic discussions during round tables as well as rich discussions (B2B) with stakeholders in the eco-system reinforced […]

Join us at PSCC Innovation Forum 2024

Today, the Paris Saclay Cancer Cluster kicks off its inaugural “Innovation Forum 2024” at the Faculty of Medicine Paris-Saclay. ๐Ÿš€ We’re excited to start this day dedicated to scientific discoveries, engaging exchanges, and fostering collaboration within our ecosystem. ๐Ÿค We look forward to meet experts, researchers, industry professionals, start-ups, patients, platform developers… in the fight […]

INCREASE IMMUNOGENICITY

Brenusโ€™ manufacturing process overpasses the lack of immunogenicity & educates the immune system ย withย visible and multi-specificย targets

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

  • Representative oncogenic drivers (TP53,BRAF,KRAS,โ€ฆ)
  • Cold & hot tumor cell lines
  • Resistances capacities (metabolic ; chemical & physical)

Increase antigenicity

Brenusโ€™ manufacturing process overpasses the lack of antigenicity & educates the immune system ย withย aย broadย &ย higherย qualityย range ofย tumorย antigens